Logo image of LMAT

LEMAITRE VASCULAR INC (LMAT) Stock Price, Quote, News and Overview

NASDAQ:LMAT - Nasdaq - US5255582018 - Common Stock - Currency: USD

90.24  -0.5 (-0.55%)

Premarket: 91 +0.76 (+0.84%)

LMAT Quote, Performance and Key Statistics

LEMAITRE VASCULAR INC

NASDAQ:LMAT (5/1/2025, 9:14:35 PM)

Premarket: 91 +0.76 (+0.84%)

90.24

-0.5 (-0.55%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High109.58
52 Week Low71.42
Market Cap2.04B
Shares22.59M
Float20.60M
Yearly Dividend0.64
Dividend Yield0.87%
PE46.52
Fwd PE39.55
Earnings (Next)05-01 2025-05-01/amc
IPO10-19 2006-10-19


LMAT short term performance overview.The bars show the price performance of LMAT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 -4 6 -6

LMAT long term performance overview.The bars show the price performance of LMAT in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of LMAT is 90.24 USD. In the past month the price increased by 4.18%. In the past year, price increased by 21.58%.

LEMAITRE VASCULAR INC / LMAT Daily stock chart

LMAT Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.38 226.99B
ISRG INTUITIVE SURGICAL INC 67.69 185.29B
BSX BOSTON SCIENTIFIC CORP 38.22 152.63B
SYK STRYKER CORP 30.68 142.75B
MDT MEDTRONIC PLC 15.65 107.17B
BDX BECTON DICKINSON AND CO 12.19 48.68B
EW EDWARDS LIFESCIENCES CORP 28.92 44.20B
IDXX IDEXX LABORATORIES INC 41.9 38.20B
RMD RESMED INC 26.05 34.73B
GEHC GE HEALTHCARE TECHNOLOGY 14.71 30.98B
DXCM DEXCOM INC 42.58 27.55B
PHG KONINKLIJKE PHILIPS NVR- NY 15.81 23.48B

About LMAT

Company Profile

LMAT logo image LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 651 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. The company also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.

Company Info

LEMAITRE VASCULAR INC

63 2nd Ave

Burlington MASSACHUSETTS 01803 US

CEO: George W. LeMaitre

Employees: 622

Company Website: https://www.lemaitre.com/

Investor Relations: http://ir.lemaitre.com

Phone: 17812212266

LEMAITRE VASCULAR INC / LMAT FAQ

What is the stock price of LEMAITRE VASCULAR INC today?

The current stock price of LMAT is 90.24 USD. The price decreased by -0.55% in the last trading session.


What is the ticker symbol for LEMAITRE VASCULAR INC stock?

The exchange symbol of LEMAITRE VASCULAR INC is LMAT and it is listed on the Nasdaq exchange.


On which exchange is LMAT stock listed?

LMAT stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LEMAITRE VASCULAR INC stock?

17 analysts have analysed LMAT and the average price target is 107.74 USD. This implies a price increase of 19.39% is expected in the next year compared to the current price of 90.24. Check the LEMAITRE VASCULAR INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LEMAITRE VASCULAR INC worth?

LEMAITRE VASCULAR INC (LMAT) has a market capitalization of 2.04B USD. This makes LMAT a Mid Cap stock.


How many employees does LEMAITRE VASCULAR INC have?

LEMAITRE VASCULAR INC (LMAT) currently has 622 employees.


What are the support and resistance levels for LEMAITRE VASCULAR INC (LMAT) stock?

LEMAITRE VASCULAR INC (LMAT) has a support level at 89.52 and a resistance level at 92.6. Check the full technical report for a detailed analysis of LMAT support and resistance levels.


Is LEMAITRE VASCULAR INC (LMAT) expected to grow?

The Revenue of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 8.69% in the next year. Check the estimates tab for more information on the LMAT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LEMAITRE VASCULAR INC (LMAT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LEMAITRE VASCULAR INC (LMAT) stock pay dividends?

LEMAITRE VASCULAR INC (LMAT) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.64. Check the full fundamental report for a detailed analysis of LMAT dividend history, reliability and sustainability.


When does LEMAITRE VASCULAR INC (LMAT) report earnings?

LEMAITRE VASCULAR INC (LMAT) will report earnings on 2025-05-01, after the market close.


What is the Price/Earnings (PE) ratio of LEMAITRE VASCULAR INC (LMAT)?

The PE ratio for LEMAITRE VASCULAR INC (LMAT) is 46.52. This is based on the reported non-GAAP earnings per share of 1.94 and the current share price of 90.24 USD. Check the full fundamental report for a full analysis of the valuation metrics for LMAT.


What is the Short Interest ratio of LEMAITRE VASCULAR INC (LMAT) stock?

The outstanding short interest for LEMAITRE VASCULAR INC (LMAT) is 6.35% of its float. Check the ownership tab for more information on the LMAT short interest.


LMAT Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to LMAT. When comparing the yearly performance of all stocks, LMAT is one of the better performing stocks in the market, outperforming 82.28% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

LMAT Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to LMAT. LMAT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LMAT Financial Highlights

Over the last trailing twelve months LMAT reported a non-GAAP Earnings per Share(EPS) of 1.94. The EPS increased by 44.78% compared to the year before.


Industry RankSector Rank
PM (TTM) 20.03%
ROA 7.98%
ROE 13.06%
Debt/Equity 0.5
Chartmill High Growth Momentum
EPS Q2Q%28.95%
Sales Q2Q%13.98%
EPS 1Y (TTM)44.78%
Revenue 1Y (TTM)13.63%

LMAT Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to LMAT. The Buy consensus is the average rating of analysts ratings from 17 analysts.

For the next year, analysts expect an EPS growth of 17.62% and a revenue growth 8.69% for LMAT


Ownership
Inst Owners96.19%
Ins Owners8.87%
Short Float %6.35%
Short Ratio5.48
Analysts
Analysts76.47
Price Target107.74 (19.39%)
EPS Next Y17.62%
Revenue Next Year8.69%